Cargando…
Temporal trends of a vasopressin V(2) receptor antagonist in heart failure using a nationwide database in Japan
AIMS: Real‐world data on the use of tolvaptan, an oral selective vasopressin 2 receptor antagonist, for patients with heart failure (HF) are not available in Western countries because tolvaptan is not indicated in the Western countries for volume overload in HF. This study aimed to investigate the c...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835557/ https://www.ncbi.nlm.nih.gov/pubmed/33185011 http://dx.doi.org/10.1002/ehf2.13111 |